Physician profile
Pritee Chhetri
NPI 1619406469
$314.90
in general payments reported to CMS, 2019-2025
8 companies · $25.73 in 2025
The $25.73 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $152 · 2022: $137 · 2025: $25.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $75.59 | 2021 | |
| Daiichi Sankyo INC. | $41.89 | 2021 | |
| Aurinia Pharma U.S., INC. | $41.14 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $38.40 | 2021-2022 | |
| Amgen INC. | $34.51 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.83 | 2022 | |
| Ani Pharmaceuticals, INC. | $25.81 | 2022 | |
| Janssen Pharmaceuticals, INC | $25.73 | 2025 | Invega Sustenna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pritee Chhetri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.